Temptime is a global healthcare innovator specializing in temperature-monitoring solutions. Its founder chose to partner exclusively with Water Street when he was ready to make an ownership transition in 2013, believing that Water Street was the best steward for the company and its long-term success. Over the next six years, our team facilitated strategic acquisitions, partnerships and licensing agreements that expanded Temptime’s proprietary technology into new applications, products and healthcare markets. We doubled the company’s production capacity, broadened its global footprint and significantly grew its customer base. Temptime’s impact on improving global health is significant. As the only company to offer temperature-monitoring devices approved by the world’s leading global health organizations, Temptime has enabled healthcare workers to successfully deliver more than 10 billion immunizations to children and families around the world with greater confidence in their safety and effectiveness. Zebra Technologies Corporation (NASDAQ: ZBRA) bought Temptime in 2019 as part of its strategy to expand into high-growth areas.
Renaat Van den Hooff
PresidentWork with us
Renaat Van den Hooff has more than 30 years of global leadership experience in healthcare. Prior to Temptime, he achieved a distinguished career at Johnson & Johnson, where he served as worldwide president of the company’s joint venture with Merck. He also held a number of management positions for J&J in Belgium, the United Kingdom and United States. Renaat has served as president of Temptime since 2011. He received a degree in economics from VEH – Brussels, Belgium and his master’s degree in marketing from the Vlerick Business School at the University of Ghent, Belgium. In addition to serving as a director of Temptime, he is a member of the board of trustees and executive committee of the National Multiple Sclerosis Foundation.